Literature DB >> 10746479

'Numbness of the feet' is a poor indicator for polyneuropathy in Type 2 diabetic patients.

L V Franse1, G D Valk, J H Dekker, R J Heine, J T van Eijk.   

Abstract

AIMS: To identify neuropathic sensory symptoms associated with a clinical neurological examination (CNE) and to investigate whether these symptoms could be used as a diagnostic or screening tool for diabetic polyneuropathy in general practice.
METHODS: Five hundred and eighty-eight patients with Type 2 diabetes, recruited from 26 general practices in the Netherlands, underwent a CNE and completed a diabetes symptom checklist that included 10 items on neuropathic sensory symptoms. Linear regression analyses were performed to assess the association between neuropathic symptoms and CNE. Receiver operating characteristic (ROC) curves were created to assess the diagnostic properties of neuropathic symptoms.
RESULTS: In this population, with a mean age of 66.8 years, 32% were identified with diabetic polyneuropathy according to the CNE. Variables that showed the strongest association with CNE score were age (beta = 0.41), symptoms of sensory alteration (beta = 0.27), and the item 'numbness of the feet' (beta = 0.35) in particular. ROC curves showed that prediction of diabetic polyneuropathy from these symptoms was unsatisfying. The sensitivity and specificity of daily symptoms of 'numbness of the feet' were 28% and 93%, respectively, in patients <68 years, and 22% and 92%, respectively, in patients > or =68 years.
CONCLUSIONS: Identification of neuropathic sensory symptoms is not useful as a diagnostic or even a screening tool in the assessment of diabetic neuropathy in daily practice. Therefore, the results reported in this paper mandate an annual foot examination by the general practitioner.

Entities:  

Mesh:

Year:  2000        PMID: 10746479     DOI: 10.1046/j.1464-5491.2000.00223.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  7 in total

Review 1.  Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review.

Authors:  Jacquelien Dros; Astrid Wewerinke; Patrick J Bindels; Henk C van Weert
Journal:  Ann Fam Med       Date:  2009 Nov-Dec       Impact factor: 5.166

2.  Vitamin B12 and homocysteine levels and 6-year change in peripheral nerve function and neurological signs.

Authors:  Kira Leishear; Luigi Ferrucci; Fulvio Lauretani; Robert M Boudreau; Stephanie A Studenski; Caterina Rosano; Rosanna Abbate; Anna M Gori; Anna M Corsi; Angelo Di Iorio; Jack M Guralnik; Stefania Bandinelli; Anne B Newman; Elsa S Strotmeyer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-12       Impact factor: 6.053

3.  Clinical neuropathy scales in neuropathy associated with impaired glucose tolerance.

Authors:  Lindsay A Zilliox; Sandra K Ruby; Sujal Singh; Min Zhan; James W Russell
Journal:  J Diabetes Complications       Date:  2015-02-03       Impact factor: 2.852

Review 4.  Diagnosis and management of diabetic neuropathy.

Authors:  Bruce A Perkins; Vera Bril
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

5.  Prediction of peak pressure from clinical and radiological measurements in patients with diabetes.

Authors:  Nick A Guldemond; Pieter Leffers; Geert H I M Walenkamp; Nicolaas C Schaper; Antal P Sanders; Fred H M Nieman; Lodewijk W van Rhijn
Journal:  BMC Endocr Disord       Date:  2008-12-02       Impact factor: 2.763

6.  The prevalence of diabetic peripheral neuropathy and related factors.

Authors:  O Tabatabaei-Malazy; Mr Mohajeri-Tehrani; Sp Madani; R Heshmat; B Larijani
Journal:  Iran J Public Health       Date:  2011-09-30       Impact factor: 1.429

7.  Predictors of diabetic foot and leg ulcers in a developing country with a rapid increase in the prevalence of diabetes mellitus.

Authors:  Kumarasinghe A Sriyani; Sudharshani Wasalathanthri; Priyadharshika Hettiarachchi; Shamini Prathapan
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.